Operating GMP facility in Prague, Czech Republic

SCTbio is
an European CDMO
 

SCTbio is operating a GMP cell and gene therapy manufacturing facility 
in Prague, Czech Republic. The SCTbio has also access to a viral vector manufacturing facility operated by its affiliated company based
in Cambridge, MA, USA.

MANUFACTURING FACILITY

Prague, Czech Republic

Jankovcova 2, 170 00 Prague 7
Czech Republic
4.500 sq. ft.


  • GMP clinical and commercial manufacturing capabilities

  • Class A/B/C/D clean room facility classified according to EU cGMP

  • Autoclaves – laboratory tools, cleaning material sterilization

  • DI water (de-ionized) system – water for autoclaves and cleaning

  • Laundry services outsourced via third party 

  • CO2 station with automatic switch – CO2 source for incubators

  • Vacuum pumps – vacuum source for particle counters

  • Five terminal PC with barcode readers in Class C area (LaSSo™ scheduling and raw material system access) plus two terminal PC with barcode readers outside clean premises

  • Cryostorage – five Dewar tanks, LN2 filling unit, automated filling and control

“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
Geoffrey Hodge CEO SOTIO Biotech Inc.

Cambridge

SOTIO Biotech Inc.
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic